Management of hyperactivity and other acting-out problems in patients with autism spectrum disorder-Reference-Cited by-同舟云学术

Management of hyperactivity and other acting-out problems in patients with autism spectrum disorder

Published:2004-09 Issue:3 Volume:11 Page:225-228
ISSN:1071-9091
Container-title:Seminars in Pediatric Neurology
language:en
Short-container-title:Seminars in Pediatric Neurology

Author:

Aman Michael G.

Publisher

Elsevier BV

Subject

Clinical Neurology,Pediatrics, Perinatology, and Child Health

Reference18 articles.

1. Stimulant drugs in the developmental disabilities revisited;Aman;J Dev Phys Disabil,1996

2. A naturalistic retrospective analysis of psychostimulants in pervasive developmental disorders;Stingler;J Child Adolesc Psychopharmacol,2004

3. Scahill L, Vitiello B, Aman MG, et al and the Research Units on Pediatric Psychopharmacology Autism Network: Methylphenidate in autism: Results from the RUPP Autism Network. Presented at the 41st Annual Meeting of the New Clinical Drug Evaluation Unit (NCDEU) Conference, Phoenix, AZ

4. Pharmacotherapy for hyperactivity in children with autism and other pervasive developmental disorders;Aman;J Autism Dev Disord,2000

5. Guanfacine treatment of hyperactivity and inattention in autism;Posey;J Child Adolesc Psychopharmacol,2004

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification and support of autistic individuals within the UK Criminal Justice System: a practical approach based upon professional consensus with input from lived experience;BMC Medicine;2024-04-12

2. Febrile Seizure Causes Deficit in Social Novelty, Gliosis, and Proinflammatory Cytokine Response in the Hippocampal CA2 Region in Rats;Cells;2023-10-13

3. Parenting in context: parents’ experiences of caring for a child with autism in Bangladesh;International Journal of Anthropology and Ethnology;2023-06-12

4. Targeting Shank3 deficiency and paresthesia in autism spectrum disorder: A brief review;Frontiers in Molecular Neuroscience;2023-02-09

5. Associations between β-blockers and psychiatric and behavioural outcomes: A population-based cohort study of 1.4 million individuals in Sweden;PLOS Medicine;2023-01-31